Fig. 8
From: FGF18 alleviates sepsis-induced acute lung injury by inhibiting the NF-κB pathway
FGF18 inhibits NF-κB pathway activation in ALI mice in line with MAPK kinase inhibitors. (A, B) A schematic diagram demonstrates the animal experiment design. (C) HE staining in lung tissues of MAPK kinase inhibitors-treated mice in the presence of AAV-FGF18 after LPS injection for 12 h. (n = 5 per group, Scale bar = 50 μm). (D) C57BL/6J mice were treated with AAV-FGF18 and MAPK kinase inhibitors in the presence of LPS and then subjected to western blotting analysis. (n = 5 per group)